According to a recent article by the Harvard Business Review, a growing number of employers are embracing the use of “digital therapeutics” to improve employee health and reduce costs. Today, these digital therapeutics include “consumer-grade technology such as mobile devices, wearable sensors, big data analytics, and behavioral science and can be delivered through web browsers, apps, or in conjunction with medical devices.” The use of “artificial-intelligence-driven smartphone apps,” in particular, may provide patients with real-time support and feedback for chronic conditions ranging from asthma to depression.
The Margolin Group (TMG) believes that innovative use of wearable technology is a critical part of today’s system of healthcare and coverage. Wearable technology coupled with telehealth and a robust provider network will likely help to ease the nation’s shortage of physicians and improve caregiver responsiveness.
Contact us at firstname.lastname@example.org to learn more about how TMG is working to support the adoption of wearable and telehealth technology.